Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group.
Redondo AM, Valcárcel D, González-Rodríguez AP, Suárez-Lledó M, Bello JL, Canales M, Gayoso J, Colorado M, Jarque I, Del Campo R, Arranz R, Terol MJ, Rifón JJ, Rodríguez MJ, Ramírez MJ, Castro N, Sánchez A, López-Jiménez J, Montes-Moreno S, Briones J, López A, Palomera L, López-Guillermo A, Caballero D, Martín A; Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea (GELTAMO). Redondo AM, et al. Among authors: caballero d. Br J Haematol. 2019 Mar;184(5):797-807. doi: 10.1111/bjh.15713. Epub 2018 Dec 12. Br J Haematol. 2019. PMID: 30548583 Free article. Clinical Trial.
Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative group.
Sureda A, Mataix R, Hernández-Navarro F, Jarque I, Lahuerta JJ, Tomás JF, Brunet S, Caballero D, Conde E, León A, Fernández MN, López A, Maldonado J, Bengoechea E, Callís M, Carrera D, García-Conde J, García-Laraña J, Moraleda JM, Morey M, Rifón J, Sierra J, Torres A, Domingo-Albós A. Sureda A, et al. Among authors: caballero d. Bone Marrow Transplant. 1997 Aug;20(4):283-8. doi: 10.1038/sj.bmt.1700886. Bone Marrow Transplant. 1997. PMID: 9285542
[Autologous transplant with BEAM protocol in lymphoma].
Caballero D, Rubio V, Rifon J, Heras I, García-Sanz R, Vidriales B, Pérez-Simón JA, del Cañizo C, González M, León A, Jean-Paul E, Rocha E, Vicente V, San Miguel JF. Caballero D, et al. Sangre (Barc). 1997 Apr;42 Suppl 1:46-9. Sangre (Barc). 1997. PMID: 9381303 Spanish. No abstract available.
High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: results from the EBMT. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Sweetenham JW, Taghipour G, Milligan D, Blystad AK, Caballero D, Fassas A, Goldstone AH. Sweetenham JW, et al. Among authors: caballero d. Bone Marrow Transplant. 1997 Nov;20(9):745-52. doi: 10.1038/sj.bmt.1700963. Bone Marrow Transplant. 1997. PMID: 9384476 Clinical Trial.
Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.
Alegre A, Díaz-Mediavilla J, San-Miguel J, Martínez R, García Laraña J, Sureda A, Lahuerta JJ, Morales D, Bladé J, Caballero D, De la Rubia J, Escudero A, Díez-Martín JL, Hernández-Navarro F, Rifón J, Odriozola J, Brunet S, De la Serna J, Besalduch J, Vidal MJ, Solano C, Leon A, Sánchez JJ, Martínez-Chamorro C, Fernández-Rañada JM. Alegre A, et al. Among authors: caballero d. Bone Marrow Transplant. 1998 Jan;21(2):133-40. doi: 10.1038/sj.bmt.1701062. Bone Marrow Transplant. 1998. PMID: 9489629
Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation.
Pérez-Simón JA, Martín A, Caballero D, Corral M, Nieto MJ, Gonzalez M, Vazquez L, López-Berges C, Cañizo MC, Mateos MV, Orfao A, San Miguel JF. Pérez-Simón JA, et al. Among authors: caballero d. Bone Marrow Transplant. 1999 Dec;24(12):1279-83. doi: 10.1038/sj.bmt.1702066. Bone Marrow Transplant. 1999. PMID: 10627635 Clinical Trial.
Conditioning regimens in autologous stem cell transplantation for multiple myeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple Myeloma.
Lahuerta JJ, Martinez-Lopez J, Grande C, Bladé J, de la Serna J, Alegre A, García-Laraña J, Caballero D, Sureda A, de la Rubia J, Alvarez AM, Marín J, Escudero A, Conde E, Perez-Equiza K, García Ruiz JC, Moraleda JM, León A, Bargay J, Cabrera R, Hernandez-García MT, Diaz-Mediavilla J, Miguel JS. Lahuerta JJ, et al. Among authors: caballero d. Br J Haematol. 2000 Apr;109(1):138-47. doi: 10.1046/j.1365-2141.2000.01979.x. Br J Haematol. 2000. PMID: 10848793 Free article.
Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies.
Brunet S, Urbano-Ispizua A, Ojeda E, Ruiz D, Moraleda JM, Díaz MA, Caballero D, Bargay J, de la Rubia J, Solano C, Zuazu J, Diez JL, de la Serna J, Espigado I, Alegre A, Torres JP, Jurado M, Fernández M, Vivancos P, Carreras E, Hernández F, Maldonado J, Sierra J, Rozman C; Spanish Group of Allogenic-PBT, Spain. Brunet S, et al. Among authors: caballero d. Br J Haematol. 2001 Sep;114(3):544-50. doi: 10.1046/j.1365-2141.2001.03002.x. Br J Haematol. 2001. PMID: 11552978 Free article.
308 results